newsfilter
← Latest News
Business Wire·

Spruce Biosciences Appoints Adrian Quartel, M.D., FFPM, as Chief Medical Officer

Accomplished Rare Disease Drug Developer Brings More Than 25 Years of Global Clinical Development and Medical Affairs Leadership, Including the Launch of Multiple Enzyme Replacement Therapies for Rare Pediatric and